线,

Stefano Molica1

  • 1Department of Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK.

Expert review of hematology
|February 21, 2025
PubMed
概括

慢性淋巴细胞白血病 (CLL) 的个性化治疗至关重要. 目前的指导方针需要更新,以纳入患者的偏好和现实世界的因素,以获得更好的目标治疗结果,如BTK和BCL-2抑制剂.